SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-218580
Filing Date
2022-08-11
Accepted
2022-08-11 16:23:54
Documents
5
Period of Report
2022-09-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d144681ddef14a.htm DEF 14A 101108
2 GRAPHIC g144681dsp020.jpg GRAPHIC 115960
3 GRAPHIC g144681dsp021.jpg GRAPHIC 135485
4 GRAPHIC g144681g0729204414785.jpg GRAPHIC 3063
5 GRAPHIC g144681g0729204414972.jpg GRAPHIC 2399
  Complete submission text file 0001193125-22-218580.txt   456702
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38295 | Film No.: 221156229
SIC: 2836 Biological Products, (No Diagnostic Substances)